Did Leaving the WHO Save or Cost the U.S. Money?

Published on January 23, 2026 | Prices Last Reviewed for Freshness: February 2026
Written by Alec Pow - Economic & Pricing Investigator | Content Reviewed by CFA Alexander Popinker

Educational content; not financial advice. Prices are estimates; confirm current rates, fees, taxes, and terms with providers or official sources.

The United States formally left the World Health Organization on January 22, 2026, ending a funding relationship that shaped global health coordination for decades. The clean political line is “savings,” but the real budget story is a ledger: what the U.S. stops paying into WHO versus what it may need to spend to replace access, coordination, and technical work that used to arrive through a single multilateral channel.

Two numbers anchor the debate. Reuters reported projected U.S. contributions of about $958 million for the 2026–2027 WHO budget cycle and described the U.S. as roughly 18% of WHO’s two-year programme budget. The withdrawal mechanism itself is spelled out in U.S. law: a one-year notice requirement and a requirement to meet financial obligations through the then-current fiscal year, as summarized by the Congressional Research Service and stated in the official statute text published by GovInfo.

TL;DR: If the U.S. avoided a projected $958M WHO bill for 2026–27, that averages about $1.31M per day over two years (simple math). But reported unpaid obligations and “buy-back” replacement spending can shrink that margin quickly once agencies start paying for parallel access, staffing, and contracts.

Key numbers at a glance:

• $958M: projected U.S. contributions for WHO’s 2026–27 cycle (Reuters link above).
• $6.8B: WHO’s total 2024–25 programme budget (WHO budget document linked below).
• $260.6M: U.S. assessed contributions listed for 2024–25 (WHO assessed-contributions PDF linked below).
• 2,371 jobs: planned WHO workforce reduction by mid-2026 (Reuters job-cuts link below).

Did Leaving the WHO Save or Cost the U.S. Money?

Near-term federal “savings” come from not funding the next WHO budget cycle and from halting most voluntary program support. WHO’s official Programme Budget for 2024–2025 puts the total at about $6.8 billion and lists assessed contributions across all members at roughly $1.148 billion. The U.S. share historically mixed assessed dues with large voluntary contributions, which is why the projected two-year U.S. figure for 2026–2027 was widely discussed as a single combined number.

There are offsets and timing frictions, and this is where headlines can mislead. U.S. exit terms require notice and settlement of obligations through the then-current fiscal period (CRS and GovInfo links above). Meanwhile, the amount “owed” can vary depending on what a source is counting: assessed contributions only, assessed plus arrears, or a moving number after partial payments.

Why some reports cite different “owed” totals: WHO’s own assessed-contributions schedule for 2024–2025 lists the United States at $260,625,940 for the biennium in the assessed contributions payable table. Some reporting tallies a higher “unpaid” figure by combining assessed amounts with arrears or by using a different cutoff date for what counts as outstanding. For example, OPB reported a tally around $278 million in remaining 2024–2025 dues and arrears based on finance tables and briefings. Those are not necessarily contradictory numbers; they can be different scopes.

When the notice period ended, the formal completion of the withdrawal was covered widely, including by the Associated Press. The budget question after that point becomes less about whether the U.S. “stopped paying” and more about how much it spends to replace what it used to access indirectly.

One undercovered “savings vs costs” complication is that WHO’s own planning documents treat the U.S. departure as a structural hole. WHO wrote that Member States approved a $4.2 billion base programme budget for 2026–2027 after downsizing from $5.3 billion due to financial constraints, in its budget approval announcement. The proposed budget document for that period also highlights how budget adjustments change operational workload and capacity choices in the Proposed programme budget 2026–2027.

Real-Life Cost Examples

Example 1, avoided contributions vs obligations: If the U.S. avoids the projected $958 million for the next biennium (Reuters link in the introduction), the “gross” savings headline is straightforward. But the withdrawal conditions (GovInfo statute and CRS brief linked above) also require obligations to be met through the relevant fiscal period, and some reporting has estimated remaining bills and arrears in the high $200M range (OPB link above). That creates a one-time margin between avoided future outlays and settled obligations, but it is not “pure savings.”

Example 2, replacement spending can eat the margin: Even a small reallocation inside the existing U.S. global health budget can materially shrink the headline savings. In a deep-dive on financing and implications, Reuters quantified total U.S. global health funding at $15.8 billion in 2022 across entities. Redirecting a small slice of those accounts is not hard in Washington budget terms, and it quickly becomes “real money” versus the $958M that dominates the politics.

Example 3, capacity cuts abroad are measurable outputs: When funding tightens, you can often see it in staffing and program delivery, not just spreadsheets. Reuters reported WHO planned to reduce its workforce by about 2,371 positions by mid-2026, framing it as part of downsizing pressures after the U.S. exit as a top donor. For cost modeling, that is a tangible sign that “the system” the U.S. used to buy into may operate at reduced capacity, which can shift costs onto bilateral channels.

Example 4, what the U.S. was effectively buying: WHO’s public funding pages list the United States at $1.284 billion in total contributions for 2022–2023, a useful anchor for understanding why WHO finance teams treat a U.S. departure as structural rather than symbolic, as shown in the WHO contributor profile for the United States. That historic magnitude is also why replacing access elsewhere often means recurring costs spread across agencies and contracts.

Cost Breakdown

At a basic level, the U.S. stops paying assessed contributions and many voluntary grants that flowed through WHO. Assessed dues are calculated via a member-state scale applied to countries and approved for each cycle; WHO explains how this works in its assessed contributions overview. Voluntary funding is where donor concentration and program steering become most visible, and that is also where “savings” can be easiest politically while becoming most expensive operationally if agencies need to recreate the same outcomes via contracts.

What replaces WHO-linked functions is not a slogan; it is a procurement menu. If agencies decide they need comparable access and coordination, typical replacement cost buckets include (1) additional overseas staffing and liaison roles, (2) legal and compliance work for bilateral agreements, (3) recurring contracts for data pipelines and technical support, (4) convening and travel that WHO previously centralized, and (5) standards and guideline work that must be maintained over time. The budget risk is fragmentation: a function once purchased through one multilateral channel becomes dozens of smaller line items spread across agencies and contractors, which is harder to track and easier to underestimate.

Another budget reality many reporters miss is donor concentration. WHO’s Executive Board financing paper notes that in 2024–2025 the top ten donors provided 57% (about $4.2 billion) of total available funds, a concentration described in Financing and implementation of the Programme budget. In practice, that means the impact of a large donor leaving is rarely “smoothly distributed”; it tends to force triage, deferrals, and program reshaping, which can push costs outward onto member states and bilateral channels.

Factors Influencing the Cost

Three variables change the total. First, how much of the former WHO-linked portfolio the U.S. chooses to recreate with bilateral deals or redirected grants. Second, how quickly agencies can sign workable arrangements for cross-border access, standards, and coordination that were previously brokered through a single mechanism. Third, whether partners and vendors can fill gaps cheaply, or whether prices rise as contracted alternatives replace pooled systems.

Some costs are “small per year, large when missing,” because they are operational throughput problems. WHO describes how global influenza surveillance and vaccine-related coordination workflows run through networks and repeated decision cycles; the point for budgeting is that recreating equivalent throughput through bilateral contracts is a recurring operating expense, not a one-time line item, as outlined in WHO’s Global Influenza Programme description. You do not need to make this political to price it: coordination has a carrying cost.

One Worked Scenario

This scenario is illustrative, not an audited forecast. Assume the U.S. avoids the projected $958 million for 2026–2027 (Reuters link in the introduction). Now assume outstanding obligations and arrears tied to the exit process are in the high $200M range based on the scope used in the OPB tally (OPB link above). That produces a rough near-term “gap” of several hundred million dollars.

Now add replacement spending. If agencies redirect 1% of the $15.8 billion cited for U.S. global health funding (Reuters link in the Real-Life Examples section) toward replacement access, contracts, and liaison capacity, that equals about $158 million. Under those assumptions, the “savings” margin can compress quickly, and that compression accelerates if replacement choices expand beyond minimal coverage.

Three Paths and Money at Stake

The table below summarizes money dynamics under three plausible policy paths. The concrete anchor is the projected $958M figure for 2026–2027 (Reuters link in the introduction). The “obligations paid” line reflects high-level reporting-based tallies that can vary by scope (see the “Why some reports differ” explanation above). Replacement outlays are scenario ranges meant to show sensitivity, not a single official number.

These are policy-sensitive ranges, not audited totals. The point is that the “savings” story lives or dies on replacement behavior: how much the U.S. chooses to rebuild, how it rebuilds, and whether costs stay centralized or fragment across contracts and agencies.

Hidden Costs

Hidden costs include slower access to cross-border information, more travel and negotiation to stitch together agreements, translation, legal review for dozens of bilateral accords, and price premiums when purchasing services without pooled leverage. These items rarely appear in one appropriation. They show up as delays, overruns, and overtime across multiple agencies.

One way to keep the argument money-first is to remember that rare, large-scale cross-border emergencies can produce macroeconomic disruption that dwarfs annual dues. A widely cited peer-reviewed estimate placed the economic cost of the COVID-19 crisis at roughly $16 trillion, which illustrates how small changes in early-warning and coordination efficiency can overwhelm membership-scale “savings” when tail risks materialize, as estimated in JAMA.

Expert Insights & Sources

In practical terms, the cost question comes down to whether the U.S. replaces WHO-linked functions with domestic build-outs and bilateral agreements. You can read the legal withdrawal conditions in the CRS brief and the GovInfo statute text linked in the introduction. WHO’s programme budget documents provide public baselines for total spend, assessed contributions, and planning adjustments, and WHO’s assessed-contributions schedule shows what assessed dues look like in black-and-white. Reporting and analyses quantify the U.S. funding footprint and track how WHO adapts through downsizing.

Regionality and Price Exposure

When coordination shifts from a pooled mechanism to bilateral arrangements, prices and timelines vary more by country risk, legal systems, and contracting capacity. That is not ideological; it is how procurement behaves when a single channel becomes many channels. The more fragmented the replacement approach, the more likely costs appear as dispersed line items rather than one obvious “WHO payment,” which can make savings look larger on paper than they feel operationally.

Article Highlights

• The U.S. exit took effect on January 22, 2026 (covered by the Associated Press link above), following a one-year notice process described by CRS and in the GovInfo statute text.
• Projected U.S. contributions for 2026–2027 were about $958M (Reuters link in the introduction), averaging roughly $1.31M per day over two years (simple math).
• Reported “amount owed” figures vary by scope and timing; WHO’s assessed-contributions schedule lists $260.6M for 2024–2025 assessed contributions, while some reporting tallies higher totals when including arrears or different cutoffs.
• Replacement costs can be structural: contracts, staffing, legal work, travel, and recurring coordination spend can quickly narrow headline savings.
• Funding concentration matters: WHO’s financing paper says the top ten donors provided 57% (about $4.2B) of available funds in 2024–2025, which helps explain why major donor shifts can force triage.

Answers to Common Questions

Did the U.S. have to pay anything after giving notice?

Yes. U.S. withdrawal terms require one year of notice and meeting financial obligations through the relevant fiscal period, as summarized by CRS and stated in the GovInfo statute text linked in the introduction.

How much did the U.S. typically contribute in a two-year cycle?

Totals vary by biennium and by mix of assessed versus voluntary funding. Reuters reported a projected U.S. figure of about $958M for 2026–2027, while WHO’s contributor profile lists $1.284B for 2022–2023, reflecting a different cycle and funding mix (links above).

What WHO-linked functions might the U.S. need to replicate?

If policymakers choose to replace what WHO centralized, likely cost buckets include recurring coordination contracts, standards and guideline work, bilateral agreements and legal/compliance support, expanded liaison staffing, and more convening and travel. The operational point is not politics; it is that coordination has a carrying cost.

Will U.S. agencies still cooperate with WHO scientists?

Cooperation can continue through bilateral or multilateral channels, but it relies on new agreements and tends to be less centralized, which can raise transaction costs. How expensive that becomes depends on how aggressively agencies “buy back” access and coordination.

Is the WHO budget public?

Yes. WHO publishes programme budgets and financing documents, including the programme budget PDF, proposed 2026–2027 materials, and assessed-contributions schedules linked above.